BAFNAPH.NS

Bafna Pharmaceuticals Limited [BAFNAPH.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BAFNAPH.NS Stock Summary

Top 10 Correlated ETFs

BAFNAPH.NS


Top 10 Correlated Stocks

BAFNAPH.NS


In the News

BAFNAPH.NS Financial details

Company Rating
Neutral
Market Cap
1.88B
Income
112.65M
Revenue
1.53B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
588
Optionable
No
Shortable
Yes
Earnings
22 May 2024
P/E
14.08
Forward P/E
-
PEG
1.18
P/S
1.52
P/B
2.94
P/C
-
P/FCF
-
Quick Ratio
1.1
Current Ratio
2.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
4.84
EPS next Y
-
EPS next Q
-
EPS this Y
116.74%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
21.62%
Revenue Q/Q
-30.08%
EPS Q/Q
-218.1%
-
-
-
-
SMA20
-11.24%
SMA50
-21.78%
SMA100
-8.14%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
31%
ROC
0.2%
Gross Margin
32%
Oper. Margin
11%
Profit Margin
11%
Payout
-
Shs Outstand
23.66M
Shs Float
1.92M
-
-
-
-
Target Price
-
52W Range
77.05-124.45
52W High
-36.81%
52W Low
+1.75%
RSI
31
Rel Volume
2.63
Avg Volume
8.85K
Volume
23.23K
Perf Week
-1.94%
Perf Month
-13.71%
Perf Quarter
-12.94%
Perf Half Y
-6.22%
-
-
-
-
Beta
0.525
-
-
Volatility
0.92%, 4.44%
Prev Close
0%
Price
78.35
Change
2.82%

BAFNAPH.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
18.3317.9530.1135.9948.76
Net income per share
-7.98-10.452.462.214.79
Operating cash flow per share
-0.76-14.5-5.753.42.09
Free cash flow per share
-0.9-15.11-8.330.21-1.38
Cash per share
0.063.460.320.013.3
Book value per share
8.0621.612426.5831.05
Tangible book value per share
7.9421.632426.5830.42
Share holders equity per share
8.0621.612426.5831.05
Interest debt per share
20.370.226.714.0410.55
Market cap
229.47M314.63M3.25B3B1.94B
Enterprise value
690.35M262.95M3.4B3.09B2.09B
P/E ratio
-1.22-1.2755.857.4417.11
Price to sales ratio
0.530.744.573.521.68
POCF ratio
-12.84-0.92-23.8937.339.17
PFCF ratio
-10.82-0.88-16.5610.56-59.39
P/B Ratio
1.20.625.734.762.64
PTB ratio
1.20.625.734.762.64
EV to sales
1.590.624.783.621.81
Enterprise value over EBITDA
-21.0318.6332.7323.1611.01
EV to operating cash flow
-38.63-0.77-2538.4342.22
EV to free cash flow
-32.56-0.74-17.27628.95-64.02
Earnings yield
-0.82-0.790.020.020.06
Free cash flow yield
-0.09-1.14-0.060-0.02
Debt to equity
2.430.010.280.140.31
Debt to assets
0.390.010.180.10.18
Net debt to EBITDA
-14.04-3.661.450.680.8
Current ratio
0.682.112.043.141.88
Interest coverage
-8.27-1.97K69.3612.675.78
Income quality
0.118.22-2.341.10.42
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.010.030.010.020.01
Research and developement to revenue
0.020.020.020.020.01
Intangibles to total assets
00000.01
Capex to operating cash flow
0.190.040.45-0.94-1.66
Capex to revenue
-0.01-0.03-0.09-0.09-0.07
Capex to depreciation
-0.1-0.44-1.36-1.37-1.54
Stock based compensation to revenue
00000
Graham number
38.0371.2936.4736.3257.87
ROIC
-0.26-0.50.090.080.12
Return on tangible assets
-0.16-0.350.070.060.09
Graham Net
-28.171.63-5.61-2.54-2.52
Working capital
-223.52M189.96M253.6M350.09M408.35M
Tangible asset value
188.16M511.6M567.71M628.8M719.55M
Net current asset value
-521.51M159.79M199.73M240.35M311.83M
Invested capital
2.430.010.280.140.31
Average receivables
381.91M261.95M120.36M127.74M283.05M
Average payables
340.84M260.5M116.17M115.48M204.33M
Average inventory
99.78M103.47M134.28M178.62M212.5M
Days sales outstanding
327.74115.6554.4164.02131.88
Days payables outstanding
417.68169.3985.8588.29135.63
Days of inventory on hand
98.01154.13124.01144.34105.88
Receivables turnover
1.113.166.715.72.77
Payables turnover
0.872.154.254.132.69
Inventory turnover
3.722.372.942.533.45
ROE
-0.99-0.480.10.080.15
Capex per share
-0.14-0.6-2.58-3.19-3.47

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
14.4619.1917.7317.212.02
Net income per share
1.272.442.681.05-1.24
Operating cash flow per share
1.181.391.031.051.07
Free cash flow per share
1.181.391.031.051.07
Cash per share
03.5503.320
Book value per share
033.37034.820
Tangible book value per share
032.69033.830
Share holders equity per share
033.37034.820
Interest debt per share
0.2410.740.257.20.24
Market cap
2.38B1.8B2.4B1.98B2.2B
Enterprise value
2.38B1.96B2.4B2.06B2.2B
P/E ratio
19.898.49.4519.89-18.69
Price to sales ratio
6.974.275.724.867.74
POCF ratio
85.2259.1698.9779.6386.56
PFCF ratio
85.2259.1698.9779.6386.56
P/B Ratio
02.4602.40
PTB ratio
02.4602.40
EV to sales
6.974.635.725.077.74
Enterprise value over EBITDA
48.0124.8229.449.57-200.75
EV to operating cash flow
85.2264.1298.9783.1486.56
EV to free cash flow
85.2264.1298.9783.1486.56
Earnings yield
0.010.030.030.01-0.01
Free cash flow yield
0.010.020.010.010.01
Debt to equity
00.3100.20
Debt to assets
00.1800.120
Net debt to EBITDA
01.9202.10
Current ratio
01.8802.060
Interest coverage
6.259.028.466.67-4.11
Income quality
0.930.570.381-0.86
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.04000
Research and developement to revenue
00.04000
Intangibles to total assets
00.0100.020
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
042.81028.680
ROIC
00.0600.030
Return on tangible assets
00.0400.020
Graham Net
0-2.700.20
Working capital
0408.35M78.1M467.23M0
Tangible asset value
0719.55M0800.3M0
Net current asset value
0311.83M78.1M384.43M0
Invested capital
00.3100.20
Average receivables
105.16M208.39M208.39M202.94M202.94M
Average payables
82.74M142.3M142.3M150.93M150.93M
Average inventory
107.89M111.1M111.1M146.81M146.81M
Days sales outstanding
088.79089.80
Days payables outstanding
092094.350
Days of inventory on hand
071.82091.780
Receivables turnover
01.01010
Payables turnover
00.9800.950
Inventory turnover
01.2500.980
ROE
00.0700.030
Capex per share
00000

BAFNAPH.NS Frequently Asked Questions

What is Bafna Pharmaceuticals Limited stock symbol ?

Bafna Pharmaceuticals Limited is a IN stock and trading under the symbol BAFNAPH.NS

What is Bafna Pharmaceuticals Limited stock quote today ?

Bafna Pharmaceuticals Limited stock price is $78.35 today.

Is Bafna Pharmaceuticals Limited stock public?

Yes, Bafna Pharmaceuticals Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap